Loading organizations...
§ Private Profile · Atlanta, GA, USA
Specialty pharmaceutical company marketing prescription products for pediatric, cardiovascular, neuroscience, hospital.
Arbor Pharmaceuticals is an Atlanta, Georgia-based specialty pharmaceutical company that develops, manufactures, and markets prescription medications for pediatric, cardiovascular, neuroscience, and hospital-based conditions. Prior to its acquisition, the enterprise scaled its operations to employ over 600 personnel and managed a commercial portfolio consisting of more than 20 approved pharmaceutical products. The business generated over $125 million in expected annual revenue by 2012 through the targeted commercialization of both branded and generic treatments for underserved patient populations. To fund its late-stage product development and licensing deals, the firm received significant institutional backing from major investors including KKR, JW Asset Management, and NovaQuest Private Equity. In September 2021, the company was officially acquired by and merged into Azurity Pharmaceuticals to form a significantly broader specialty healthcare organization. Arbor Pharmaceuticals was originally founded in 2006 by Jarrett Disbrow.
Arbor Pharmaceuticals has raised $34.8M across 1 funding round.
Arbor Pharmaceuticals has raised $34.8M in total across 1 funding round.
Arbor Pharmaceuticals has raised $34.8M across 1 funding round. Most recently, it raised $34.8M Debt / Series B in November 2010.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 12, 2010 | $34.8M Debt Financing | Signet Healthcare Partners | Arch Healthcare Fund, JW Asset Management | Announced |
Arbor Pharmaceuticals has raised $34.8M in total across 1 funding round.
Arbor Pharmaceuticals's investors include Signet Healthcare Partners, ARCH Healthcare Fund, JW Asset Management.